Abstract

Introduction: Covid-19 is associated with common neurological diseases including stroke.

It is believed that COVID-19-19 can cause hypercoagulability status which can induce thrombotic events which may predispose for stroke.

Objective: To document COVID-19 as a risk factor for Ischemic Stroke.

Case Report: A 62 years Sudanese male known diabetic, hypertensive, hypercholesterolemia, presented to the casualty with left sided weakness. Full medical history and physical examination was done, routine and specific investigations were done.

Result: The patient, presented with left sided weakness, started suddenly. Both left upper and lower limbs were affected at the same time. He became completely paralyzed within less than six hours. Deviation of the mouth to the right side is noted. Physical examination revealed weakness in the left side of the body (left upper and lower limbs) where the power was grade zero in both limbs plus hypotonia and areflexia. Laboratory investigations were: Complete hemogram rather than lymphopenia no abnormalities were detected, ECG: left ventricular hypertrophy plus left access deviation, Chest X-ray showed evidence of cardiac enlargement and mid zonal pneumonia, chest showed evidence of bilateral ground glass appearance. Test for COVID-19 was positive, CT brain showed an evidence of right Cerebral infarction, D-dimer is elevated, C-reactive protein: 16.2mg/dl.

Conclusion: Strokes are being reported as a complication of COVID-19 due to the hypercoagulability state induced by Covid-19 infection.

Keywords: Covid-19; CT Brain; Chest X-ray

References

1. Casadevall A and Pirofski LA. “The convalescent sera option for containing COVID-19”. Journal of Clinical Investigation 130 (2020): 1545-1548.
2. Wang D., et al. “Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China”. JAMA 323 (2020): 1061-1069.
3. McGonagle D., et al. “Interleukin-6 use in COVID-19 pneumonia related macrophage activation syndrome”. Autoimmunity Review6 (2020): 102537.
4. Kidwell CS and Warach S. "Acute ischemic cerebrovascular syndrome: diagnostic criteria". Stroke12 (2003): 2995-2998.
5. Bamford J., et al. “Classification and natural history of clinically identifiable subtypes of cerebral infarction". The Lancet8756 (1991): 1521-1526.
6. Harbison J., et al. “Rapid ambulance protocol for acute stroke". The Lancet9168 (1999): 1935.
7. Hart RG., et al. “Embolic Stroke of Undetermined Source: A Systematic Review and Clinical Update". Stroke 4 (2017): 867-872.
8. Steardo L., et al. “Neuroinfection may contribute to pathophysiology and clinical manifestations of COVID-19”. Acta Physiology (Oxf) 229.3 (2020): e13473.
9. Tsai LK., et al. “Neurological manifestations in severe acute respiratory syndrome”. Acta Neurology Taiwan 14 (2005): 113-119.
10. Khosravani H., et al. “Protected Code Stroke: Hyperacute Stroke Management During the Coronavirus Disease 2019 (COVID-19) Pandemic”. Stroke6 (2020).
11. Umapathi T., et al. “Large artery ischaemic stroke in severe acute respiratory syndrome (SARS)”. Journal of Neurology 251 (2004): 1227-1231.
12. Hoffmann M., et al. “SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor”. Cell2 (2020): 271-280.e8.

Citation

Citation: Khabab Abbasher Hussien Mohamed Ahmed., et al. “COVID-19 as a Risk Factor for Ischemic Stroke, A Case Report, Khartoum, Sudan, 2020”. Acta Scientific Neurology 4.11 (2021): 18-21.

Copyright

Copyright: © 2021 Khabab Abbasher Hussien Mohamed Ahmed., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.